Effect of diet and omega-3 fatty acids in NAFLD

Romanian Journal of Morphology and Embryology

Volumn 54, Issue 3 SUPPL., 2013, Pages 785-790

  Popescu, Laura Anca ^a   Vîrgolici, Bogdana ^a   Lixandru, Daniela ^a   Miricescu, Daniela ^a   Condruţ, Elvira ^b   Timnea, Olivia ^c   Ranetti, A E ^a   Militaru, Manuella ^b   Mohora, Maria ^a   Zagrean L ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF AGRONOMIC SCIENCES AND VETERINARY MEDICINE OF BUCHAREST   (Romania)

^c ECOLOGICAL UNIVERSITY OF BUCHAREST   (Romania)

Author keywords

Diet; Mice; NAFLD; Omega 3 fatty acids; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; OMEGA 3 FATTY ACID;

ANIMAL; ARTICLE; BLOOD; DIET; DIET THERAPY; FATTY LIVER; LIVER; MALE; METABOLISM; MOUSE; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOLOGY;

ANIMALS; BIOLOGICAL MARKERS; DIET; FATTY ACIDS, OMEGA-3; FATTY LIVER; LIVER; MALE; MICE; OXIDATIVE STRESS;

EID: 84889603581     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Valenzuela R, Videla LA, The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity, Food Funct, 2011, 2(11): 644-648.
2. Quiroga AD, Li L, Trötzmüller M, Nelson R, Proctor SD, Köfeler H, Lehner R, Deficiency of carboxylesterase 1/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia, Hepatology, 2012, 56(6): 2188-2198.
3. Assy N, Nutritional recommendations for patients with nonalcoholic fatty liver diseases, World J Gastroenterol, 2011, 17(29): 3375-3376.
4. González-Périz A, Horrillo R, Ferré N, Gronert K, Dong B, Morán-Salvador E, Titos E, Martínez-Clemente M, López-Parra M, Arroyo V, Clària J, Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins, FASEB J, 2009, 23(6): 1946-1957.
5. Alexander-Aguilera A, Berruezo S, Hernández-Diaz G, Angulo O, Oliart-Ros R, Dietary n-3 polyunsaturated fatty acids modify fatty acid composition in hepatic and abdominal adipose tissue of sucrose-induced obese rats, J Physiol Biochem, 2011, 67(4): 595-604.
6. Perez-Martinez P, Perez-Jimenez F, Lopez-Miranda J, n-3 PUFA and lipotoxicity, Biochim Biophys Acta, 2010, 1801(3): 362-366.
7. Delarue J, LeFoll C, Corporeau C, Lucas D, N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod Nutr Dev, 2004, 44(3): 289-299.
8. Daugherity EK, Balmus G, Al Saei A, Moore ES, Abi Abdallah D, Rogers AB, Weiss RS, Maurer KJ, The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease, Cell Cycle, 2012, 11(10): 1918-1928.
9. Beutler E, Duron O, Kelly BM, Improved method for determination of blood glutathione, J Lab Clin Med, 1963, 61: 882-888.
10. Esterbauer H, Cheeseman KH, Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. In: Packer L, Glazer AN (eds), Methods in enzymology. Vol. 186: Oxygen radicals in biological systems. Part B: Oxygen radicals and antioxidants, Elsevier, 1990, 407-421.
11. Miller NJ, Johnston JD, Collis CS, Rice-Evans CA, Serum total antioxidant activity after myocardial infarction, Ann Clin Biochem, 1997, 34(Pt 1): 85-90.
12. Di Minno MN, Russolillo A, Lupoli R, Ambrosino P, Di Minno A, Tarantino G, Omega-3 fatty acids for the treatment of nonalcoholic fatty liver disease, World J Gastroenterol, 2012, 18(41): 5839-5847.
13. Mager DR, Patterson C, So S, Rogenstein CD, Wykes LJ, Roberts EA, Dietary and physical activity patterns in children with fatty liver, Eur J Clin Nutr, 2010, 64(6): 628-635.
14. Shapiro H, Tehilla M, Attal-Singer J, Bruck R, Luzzatti R, Singer P, The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease, Clin Nutr, 2011, 30(1): 6-19.
15. Abete I, Goyenechea E, Zulet MA, Martínez JA, Obesity and metabolic syndrome: potential benefit from specific nutritional components, Nutr Metab Cardiovasc Dis, 2011, 21(Suppl 2): B1-B15.
16. Shirouchi B, Nagao K, Inoue N, Ohkubo T, Hibino H, Yanagita T, Effect of dietary omega 3 phosphatidylcholine on obesityrelated disorders in obese Otsuka Long-Evans Tokushima fatty rats, J Agric Food Chem, 2007, 55(17): 7170-7176.
17. Schirmer SH, Werner CM, Binder SB, Faas ME, Custodis F, Böhm M, Laufs U, Effects of omega-3 fatty acids on postprandial triglycerides and monocyte activation, Atherosclerosis, 2012, 225(1): 166-172.
18. Mozaffarian D, Wu JH, (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? J Nutr, 2012, 142(3): 614S-625S.
19. Yanagita T, Nagao K, Functional lipids and the prevention of the metabolic syndrome, Asia Pac J Clin Nutr, 2008, 17(Suppl 1): 189-191.
20. Valenzuela R, Espinosa A, González-Mañán D, D'Espessailles A, Fernández V, Videla LA, Tapia G, N-3 long-chain polyunsaturated fatty acid supplementation significantly reduces liver oxidative stress in high fat induced steatosis, PLoS One, 2012, 7(10): e46400.
21. Udupa AS, Nahar PS, Shah SH, Kshirsagar MJ, Ghongane BB, Study of comparative effects of antioxidants on insulin sensitivity in type 2 diabetes mellitus, J Clin Diagn Res, 2012, 6(9): 1469-1473.
22. Szalman K, Bancu L, Sin A, Correlations between anthropometric and serologic elements of metabolic syndrome and histopathologic features of nonalcoholic fatty liver disease, Rom J Morphol Embryol, 2013, 54(1): 173-178.
23. Bǎloşeanu CL, Streba CT, Vere CC, Comǎnescu V, Rogoveanu I, Association between liver histology, carotid ultrasonography and retinal vascular changes in patients with nonalcoholic fatty liver disease (NAFLD), Rom J Morphol Embryol, 2012, 53(3): 609-614.
24. Rodríguez-Hernández H, Gonzalez JL, Márquez-Ramirez MD, Flores-Hernandez M, Rodríguez-Morán M, Guerrero-Romero F, Risk factors associated with non-alcoholic fatty liver disease and its relationship with the hepatic histological changes, Eur J Gastroenterol Hepatol, 2008, 20(5): 399-403.
25. Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G, Fatty infiltration of liver in hyperlipidemic patients, Dig Dis Sci, 2000, 45(10): 1929-1934.
26. Oliveira CP, Coelho AM, Barbeiro HV, Lima VM, Soriano F, Ribeiro C, Molan NA, Alves VA, Souza HP, Machado MC, Carrilho FJ, Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease, Braz J Med Biol Res, 2006, 39(2): 189-194.
27. Parra D, Bandarra NM, Kiely M, Thorsdottir I, Martínez JA, Impact of fish intake on oxidative stress when included into a moderate energy-restricted program to treat obesity, Eur J Nutr, 2007, 46(8): 460-467.
28. Zamani-Moghaddam E, Azami K, Minaei-Zangi B, Mousavi SZ, Sabzevari O, Protective activity of Fumaria vaillantii extract and monomethyl fumarate on acetaminophen induced hepatotoxicity in mice, Int J Pharmacol, 2012, 8(3): 177-184.